Introduction
Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology. Both T and B lymphocytes have a role in the pathogenesis of the disease. RA is an inflammatory disease characterized by remissions and exacerbation. It is also characterized by symmetrical, destructive and deforming polyarthritis involving small and large synovial joints with associated systemic disturbances, in addition to extra-articular features and the presence of circulating antiglobulin antibodies (rheumatoid factors). The disease activity of RA is assessed by the Disease Activity Score of 28 joints (DAS28). It is an indicator of RA disease activity and response to treatment. The joints included in DAS28 are bilateral: 10 (proximal interphalangeal, metacarpophalangeal joints), 2 (wrists joints, elbows joints, shoulders joints and knees joints). The number of joints with tenderness upon touching (TEN28) and swelling (SW28) are counted. The ESR is measured. Also, the patient makes a subjective assessment (VAS) of disease activity. Vitamin D3 deficiency may increase the risk for the development of RA.
1 RA is three to five times more in women than in men. 2 The frequency of disease in developed countries ranges from 0.5-1% of adults, it mean, 5 to 50 per 100,000 people developing the condition each year.
It is synthesized in the skin by the action of ultraviolet irradiation 4 . Vitamin D3 has been found to have immunomodulatory actions. There is no relationship between season and incidence of RA, but the season may affect on disease activity. The mechanism behind this finding is unclear 5 . Recently reported an inverse association between disease activity and vitamin D3 in patients with early polyarthritis. 6 This demonstrated a reduction in RA disease activity with vitamin D3 supplementation. 6 The 25 (OH) D-1-α-hydroxylase enzymes are expressed in many cells of the immune system including macrophages and dendritic cells. The 1, 25(OH) vitamin D leads to inhibition of T-cell proliferation and decreases the production of Th1 cytokines IL-2, IFN-γ and TNF-α. The VDR has been found in macrophages, chondrocytes and synoviocytes in rheumatoid synovium and sites of cartilage erosion in RA patients. 7 Vitamin D3 deficiency is involved in the pathogenesis of RA, and activity of RA .8,9 Vitamin D3 deficiency will be defined as 25 (OH)vitamin D level below 25 nmol/l (10 ng/ ml), vitamin D3 insufficiency will be defined as 25 (OH) vitamin D level 25-75 nmol/l (10-30ng/ml) and vitamin D3 sufficiency will be defined as 25 (OH) vitamin D level 75-250 nmol/l (30-100 ng/ml). 10 No similar studies have been conducted before in Kurdistan region and the whole Iraq to the authors' knowledge. This study was designed to assess the relations between vitamin D3 with RA in patients living in Erbil city.
drugs (rifampicin, oral contraceptive, carbamazepine, antiepileptic, haloperidol, phenobarbitone) were excluded. Fifty age matched controls were also chosen by convenience method of sampling who underwent a full history and physical examination and serology test (RF and Anticcp) to confirm that they are not affected by RA. Their mean age and standard deviation (SD) was 46.42±10.86 years. Data were collected and recorded on a specially designed questionnaire after getting verbal consent from the patients. Five ml of venous blood was collected from all patients and controls by clean venipuncture using plastic disposable syringes. Blood was allowed to clot before centrifugation and serum were taken. Serum concentrations of vitaminD3 were tested using (cobas e 411, S.N=1222.22 VITD-T 05894913) Vitamin D3 was measured for each patient and control. Vitamin D3 deficiency were defined as 25(OH) vitamin D level below 25 nmol/l (10 ng/ml), vitamin D3 insufficiency were defined as 25 (OH) vitamin D level 25-75 nmol/l (10-30ng/ml) and vitamin D3 sufficiency were defined as 25 (OH) vitamin D level 75-250 nmol/l (30-100 ng/ ml). 10 Effective sun exposure on vitamin D3 should be > 20 min. 11 Walking exercise increases the level of vitamin D3 > 30 min daily. 12 About drug history RA patient's treatment are (DEMARD alone, combined DEMARDs or DEMARD + Biological agent). 13, 14 The activity of disease was assessed by DAS28 and CDAI parameters. Based on DAS28 patients were graded as in remission <2.3, low active <2.7, moderate 2.7-4.1 and highly active >4.1 and for CDAI were entitled in to in remission <2.8, low active<10, moderate 10-22 and highly active >22. Erythrocyte sedimentation rate and latex test were done for the patients. The data were managed by Excel using Chi-square test. A P value less than 0.05 was considered statistically significant.
Methods
This case-control study was carried out in the Rheumatology and Medical Rehabilitation Department of Rizgary Teaching Hospital in Erbil city from April 2015 to March 2016. Fifty patients who fulfilled EULAR-ACR-2010 and ACR 1987 criteria for RA were chosen by a convenience method of sampling, and those patients who were on vitamin D3, chronic renal failure, diabetes mellitus, malabsorption, patients on enzyme induced
Results
A total of 100 participants enrolled in the study, the vast majority of them were female (92%) and the female to male ratio was 11.5:1. The study involved 50 RA patients, with 50 age matched control groups. Their mean age and SD was 46.42±10.86 years, ranging from 20 to 65 years. Figure 1 shows that 34% of patients were in the sixth decade and 32% were in the fifth decade of life. There was no significant statistical association between vitamin D3 level and participants' age (P = 0.84) as shown in Table 1 . There was a significant statistical association between vitamin D3 levels and study groups as 70% of cases had deficient vitamin D3 levels, while only 46% of control group suffered from vitamin D3 deficiency (P = 0.04) as shown in Table 2 . There was a significant statistical association between the study groups and BMI, sun exposure and vitamin D3 concentrations. The average BMI of rheumatoid patients was higher than that of the control group (P = 0.01). The vast majority (98%) of patients were exposed to less than 20 minutes in contrast to 72% of non-rheumatoid participants. 70% of cases had deficient vitamin D3 levels, while 46% of control group suffered from vitamin D3 deficiency (P = 0.04). There was a non-significant statistical relationship between study groups and walking. The majority of both groups were walking less than half an hour per day (P = 0.47).
The details are shown in Table 3 . There was a non-significant statistical relationship between vitamin D3 levels and duration of disease, DAS28, CDAI and medications taken by the patients. Most of the rheumatoid patients with different vitamin D3 concentrations i.e. whether sufficient, insufficient or deficient levels had the disease for more than five years, with positive RF, moderate DAS28 and CDAI activities and history of taking methotrexate as their first drug of choice (P >0.05) as shown in Table 4 . 15, 16 This study was conducted with the objective to evaluate serum vitamin D3 levels in patients with rheumatoid arthritis and to compare it with controls and disease activity. In this study, vitamin D3 deficiency was more common in patients with RA than in healthy controls and even mean serum vitamin D3 level in patients with RA was found to be significantly low compared to healthy controls. 70% of cases had deficient vitamin D3 levels, while 46% of control group suffered from vitamin D3 deficiency p value < 0.05. As in Table 3 20 did not agree with our study as the result was vitamin D3 deficiencies was similar in both RA patients and controls (99.1% versus 100%). Although, the mean serum vitamin D 3 level was less among RA patients than among controls, but there was no statistically significant difference (5.98 ± 6.8 nmol/l versus 8.4 ± 9.6 nmol/l, P =0.06). Vitamin D3 deficiency might be endemic in Egypt. This may be attributed to decreased sun exposure (conservative dressing culture, wearing of veil and muffler, and/or avoidance of exposure to hot sunny weather). In our research there is no relation between serum vitamin D3 and disease activity which measured by DAS28 and CDAI, in both of them I took (VAS) patients assessment of disease activity which may have affected the result of disease activity. And this result supported by Craig, et al. 21 which failed to discover a statistically significant association between vitamin D3 and DAS28 following multivariate adjustments in recent-onset rheumatoid arthritis patients. Cutolo, et al. 22 found a remarkable negative correlation between vitamin D3 and DAS28 in summer only in Southern European (Italian) patients and in winter in northern European (Estonian) patients, but no significant differences with respect to vitamin D3 values between Estonian and Italian RA patients and their controls. Research which doesn't agree with my result in disease activity and vitamin D3 are in an open-labeled randomized trial comparing triple disease-modifying antirheumatic drug (DMARD) therapy and 500 IU vitamin D3 + calcium combination versus triple DMARD and calcium alone by Gopinath et al., low levels of serum vitamin D3 were related to moderate-high disease activity in and supplementation of 500 IU of vitamin D3 daily was given to previously DMARD-naïve patients with early rheumatoid arthritis along with triple DMARD therapy showed significantly higher pain relief (50%vs. 30%, P = 0.006) in patient group than healthy controls. [23] [24] [25] Low vitamin D3 levels may be associated with higher incidence of RA, as has already been mentioned by Song, et al. 26 Other research done in India 27 which the result was against my research results, Thirty-one patients had high disease activity (DAS-28 score>5.1), 32 patients had moderate disease activity (DAS28 score 3.2-5.1) and 17 patients had low disease activity (DAS-28 score <3.2). Vitamin D3 level in high disease activity group was significantly low compared to
Discussion
Serum vitamin D3 levels are lower in rheumatoid arthritis patients and not associated with RA disease activity. Further studies with larger sample sizes and more standardized, unbiased methods are required to elucidate a causal role of vitamin D3 in RA and thus to bring about new approaches for prevention and treatment of this disease. Additional prospective, long-term studies are needed to comprehensively determine the role of vitamin D3 in developing RA and relation with disease activity. Vitamin D3 screening should be recommended for every RA patient in Erbil city.
vitamin D3 level in patients with low and moderate disease activity (P <0.001) and vitamin D3 level had significant negative correlation with DAS28 score (P <0.001). Vitamin D3 has immunoregulatory activity and vitamin D3 receptors are present in a number of cells of the immune system. 28 Immunomodulation is mediated via (VDR) vitamin D3 receptor present on antigen presenting cell, activated T lymphocyte and activated B lymphocyte. Vitamin D3 leads to induction of regulatory T cell and NK T cell while vitamin D inhibits TH1 cell response, so vitamin D3 suppresses autoimmunity. RA is also a TH1 cell mediated disorder so vitamin D3 deficiency or insufficiency may be one of the several environmental causes leading to the development of RA. Monolagas et al. found that significantly greater proportion of seropositive RA patients (76%) had lymphocyte possessing vitamin D3 receptor compared with healthy controls which was (18%). 29 Cherniak also studied that 84% prevalence of vitamin D3 insufficiency (serum level <30 ng/ml) in RA patients. 30 The strong point it was a prospective case-control study in case and control there was age and sex match. There are some weak points in our study, the selection of cases was not through random sampling and certainly, there was selection bias. Also, DAS28 and CDAI which depend on patient scoring for disease activity as I mentioned it might affect the result also tenderness score may be exaggerated by the patient. More research required to know either vitamin D3increase the risk of RA development. About sun exposure it was less in the cases may be due to immobility, recurrent admission, and deformity of the upper and lower limb of the patients. This difference could be due to potential geographical factors, lifestyle and eating habits and lack of exercise, lack of enough sun exposure, obesity may effect on vitamin D3 absorption and inadequate dairy product, so my recommendation to the patients even controls are sun exposure should not be less than 20 min
Conclusion
and vitamin D3 supplementation, Vitamin D3 insufficiency and deficiency among RA patients should be corrected.
